Variant report

Variant	nsv1026919
Chromosome Location	chr6:34495371-34517857
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:85)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:85 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr6:34502654..34506400-chr6:34510960..34515406,9	MCF-7	breast:
2	chr6:34494469..34496151-chr6:34577655..34579267,2	K562	blood:
3	chr6:34494831..34497738-chr6:34508657..34510396,2	MCF-7	breast:
4	chr6:34504144..34505003-chr6:34514225..34514901,2	MCF-7	breast:
5	chr6:34490944..34493717-chr6:34499736..34502529,2	K562	blood:
6	chr6:34497199..34497799-chr6:34557125..34558123,2	MCF-7	breast:
7	chr6:34495305..34497309-chr6:34500179..34501973,2	K562	blood:
8	chr6:34493240..34495795-chr6:34548549..34550240,2	K562	blood:
9	chr6:34131307..34131807-chr6:34494733..34495454,2	K562	blood:
10	chr6:34382272..34384689-chr6:34494911..34496600,2	K562	blood:
11	chr6:34496034..34498791-chr6:34510835..34512433,2	K562	blood:
12	chr6:34511760..34514306-chr6:34515453..34517552,2	K562	blood:
13	chr6:34509583..34511363-chr6:34518250..34520010,2	K562	blood:
14	chr6:34494545..34497462-chr6:34498275..34503019,6	MCF-7	breast:
15	chr6:34491195..34497458-chr6:34528901..34533837,5	K562	blood:
16	chr6:34502047..34504010-chr6:34512836..34514494,2	K562	blood:
17	chr6:34459450..34460981-chr6:34494263..34495839,2	K562	blood:
18	chr6:34214520..34216995-chr6:34493716..34495769,3	K562	blood:
19	chr6:34507633..34511172-chr6:34512304..34515175,5	K562	blood:
20	chr6:34505107..34506692-chr6:34515801..34518168,2	MCF-7	breast:
21	chr6:34496140..34497736-chr6:34570571..34572929,2	MCF-7	breast:
22	chr6:34494831..34497738-chr6:34508657..34510396,2	MCF-7	breast:
23	chr6:34502654..34506400-chr6:34510960..34515406,9	MCF-7	breast:
24	chr6:34391920..34394016-chr6:34508628..34510815,2	MCF-7	breast:
25	chr6:34480102..34483166-chr6:34493351..34495807,3	MCF-7	breast:
26	chr6:33686485..33689308-chr6:34514444..34516167,2	MCF-7	breast:
27	chr6:34491359..34493717-chr6:34499044..34502529,3	K562	blood:
28	chr6:34494038..34495878-chr6:34511727..34514586,2	K562	blood:
29	chr6:34392242..34394733-chr6:34507409..34509642,2	MCF-7	breast:
30	chr6:34503128..34505845-chr6:34536309..34539232,2	K562	blood:
31	chr6:34508152..34511012-chr6:34535080..34537020,2	K562	blood:
32	chr6:34501585..34503222-chr6:34504276..34506644,2	K562	blood:
33	chr6:34496932..34498060-chr6:34528153..34529212,4	MCF-7	breast:
34	chr6:34495679..34498360-chr6:34503054..34505628,3	MCF-7	breast:
35	chr6:34494873..34497912-chr6:34521168..34524393,3	MCF-7	breast:
36	chr6:34502047..34504010-chr6:34512836..34514494,2	K562	blood:
37	chr6:34498077..34501386-chr6:34521162..34524580,5	MCF-7	breast:
38	chr6:34504144..34505003-chr6:34514225..34514901,2	MCF-7	breast:
39	chr6:34494680..34495634-chr6:34577124..34578035,2	MCF-7	breast:
40	chr6:34481304..34483971-chr6:34501598..34503855,2	K562	blood:
41	chr6:34493632..34501782-chr6:34512451..34525873,25	MCF-7	breast:
42	chr6:34503783..34506203-chr6:34577530..34580135,3	MCF-7	breast:
43	chr6:34494049..34496847-chr6:34497897..34503319,6	K562	blood:
44	chr6:34514736..34516500-chr6:34519380..34521095,2	K562	blood:
45	chr6:34496704..34498115-chr6:34576145..34578099,12	MCF-7	breast:
46	chr6:34508607..34511346-chr6:34567639..34570139,2	K562	blood:
47	chr6:34495305..34497309-chr6:34500179..34501973,2	K562	blood:
48	chr6:34492976..34496422-chr6:34570016..34572960,3	MCF-7	breast:
49	chr6:34514809..34519137-chr6:34522826..34525341,4	K562	blood:
50	chr6:34505107..34506692-chr6:34515801..34518168,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000186577	chromatin interactions
ENSG00000124614	chromatin interactions
ENSG00000196114	chromatin interactions
ENSG00000124507	chromatin interactions
ENSG00000137309	chromatin interactions
ENSG00000270800	chromatin interactions
ENSG00000124664	chromatin interactions

Extended variants
information (count: 1005 )
Associated
traits (count: 106 )

Variant overlapped rSNPs/rCNVs (count:1005 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs563627623	chr6:34495376-34495377	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs151033864	chr6:34495380-34495381	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs552637955	chr6:34495393-34495394	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs374203760	chr6:34495405-34495406	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs113469983	chr6:34495406-34495407	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs140022027	chr6:34495437-34495438	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs60358080	chr6:34495448-34495449	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs76006499	chr6:34495460-34495461	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs61312305	chr6:34495462-34495463	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs184138235	chr6:34495472-34495473	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs149845498	chr6:34495495-34495496	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs550676378	chr6:34495504-34495505	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs549957909	chr6:34495551-34495552	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs527999115	chr6:34495583-34495584	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs145824248	chr6:34495646-34495647	Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs539028031	chr6:34495659-34495660	Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs189855466	chr6:34495723-34495724	Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs572795858	chr6:34495752-34495753	Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs534134627	chr6:34495834-34495835	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs555229612	chr6:34495855-34495856	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs13192349	chr6:34495910-34495911	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs117272103	chr6:34495916-34495917	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs549651838	chr6:34495952-34495953	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs539421964	chr6:34495970-34495971	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs544406932	chr6:34496001-34496002	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs59778290	chr6:34496014-34496015	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs114901408	chr6:34496059-34496060	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs140644719	chr6:34496071-34496072	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs561206610	chr6:34496080-34496081	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs368273334	chr6:34496114-34496115	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs540922961	chr6:34496130-34496131	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs562110398	chr6:34496157-34496158	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs115556929	chr6:34496171-34496172	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs386700076	chr6:34496174-34496175	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs568591876	chr6:34496175-34496176	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs111252578	chr6:34496179-34496180	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs532911152	chr6:34496203-34496204	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs550953745	chr6:34496211-34496212	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs11755909	chr6:34496239-34496240	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs375818481	chr6:34496243-34496244	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs370177862	chr6:34496250-34496251	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs555656687	chr6:34496277-34496278	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs533766747	chr6:34496305-34496306	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs553516587	chr6:34496340-34496341	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs567483305	chr6:34496362-34496363	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs201843830	chr6:34496376-34496377	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs372896925	chr6:34496382-34496383	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs540470420	chr6:34496471-34496472	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs374966564	chr6:34496473-34496474	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs201050007	chr6:34496498-34496499	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:106)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Autoimmune disease	19135723	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Amyotrophic lateral sclerosis	20685689	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:567 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:34489000-34495600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
2	chr6:34494000-34495400	Active TSS	Rectal Smooth Muscle	rectum
3	chr6:34494000-34495600	Enhancers	Primary B cells from cord blood	blood
4	chr6:34494000-34495600	Enhancers	Primary B cells from peripheral blood	blood
5	chr6:34494000-34495600	Enhancers	Primary T helper cells PMA-I stimulated	--
6	chr6:34494000-34495800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
7	chr6:34494200-34495400	Enhancers	Primary hematopoietic stem cells short term culture	blood
8	chr6:34494200-34495400	Enhancers	Esophagus	oesophagus
9	chr6:34494200-34495400	Enhancers	Placenta	Placenta
10	chr6:34494200-34495400	Genic enhancers	Right Atrium	heart
11	chr6:34494200-34495600	Enhancers	Primary T cells from cord blood	blood
12	chr6:34494200-34495600	Enhancers	Primary T helper naive cells from peripheral blood	blood
13	chr6:34494200-34495600	Enhancers	Primary T helper cells fromperipheralblood	blood
14	chr6:34494200-34495600	Enhancers	Primary T killer memory cells from peripheral blood	blood
15	chr6:34494200-34495800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
16	chr6:34494200-34496000	Enhancers	A549	lung
17	chr6:34494400-34495400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
18	chr6:34494400-34495400	Active TSS	Fetal Brain Female	brain
19	chr6:34494400-34495400	Active TSS	Pancreatic Islets	Pancreatic Islet
20	chr6:34494400-34495400	Flanking Active TSS	Dnd41	blood
21	chr6:34494400-34495400	Enhancers	HMEC	breast
22	chr6:34494400-34495400	Enhancers	HUVEC	blood vessel
23	chr6:34494400-34495600	Enhancers	Brain Hippocampus Middle	brain
24	chr6:34494400-34495800	Enhancers	Stomach Mucosa	stomach
25	chr6:34494600-34495400	Active TSS	HUES64 Cell Line	embryonic stem cell
26	chr6:34494600-34495400	Active TSS	iPS-18 Cell Line	embryonic stem cell
27	chr6:34494600-34495400	Active TSS	iPS-20b Cell Line	embryonic stem cell
28	chr6:34494600-34495400	Flanking Active TSS	Primary T cells fromperipheralblood	blood
29	chr6:34494600-34495400	Active TSS	Brain Cingulate Gyrus	brain
30	chr6:34494600-34495400	Active TSS	Colon Smooth Muscle	Colon
31	chr6:34494600-34495400	Active TSS	Fetal Lung	lung
32	chr6:34494600-34495400	Active TSS	Stomach Smooth Muscle	stomach
33	chr6:34494600-34495400	Active TSS	Hela-S3	cervix
34	chr6:34494600-34495600	Active TSS	ES-I3 Cell Line	embryonic stem cell
35	chr6:34494600-34495600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
36	chr6:34494600-34495600	Active TSS	Thymus	Thymus
37	chr6:34494800-34495400	Active TSS	H9 Cell Line	embryonic stem cell
38	chr6:34494800-34495400	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr6:34494800-34495400	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
40	chr6:34494800-34495400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
41	chr6:34494800-34495400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr6:34494800-34495400	Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
43	chr6:34494800-34495400	Active TSS	Fetal Kidney	kidney
44	chr6:34494800-34495400	Active TSS	HSMM	muscle
45	chr6:34494800-34495400	Active TSS	NH-A	brain
46	chr6:34494800-34495400	Active TSS	NHLF	lung
47	chr6:34494800-34495400	Active TSS	Osteobl	bone
48	chr6:34494800-34495600	Active TSS	iPS-15b Cell Line	embryonic stem cell
49	chr6:34495000-34495400	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
50	chr6:34495000-34495400	Enhancers	Placenta Amnion	Placenta Amnion

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links